Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01044901 · ClinicalTrials.gov registry record

Cardiovascular Complications of Sickle Cell Disease

A clinical trial, sponsored by University of Chicago.

Completed
Registry status
51
Enrollment target

NCT01044901: Completed study, sponsored by University of Chicago.

NCT01044901 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01044901 has completed, sponsored by University of Chicago.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

In this research study, we are using heart imaging exams and blood testing, in order to gain an improved understanding of the pulmonary (lung) hypertension and cardiovascular (heart) complications that often occur in sickle cell patients. Information gathered from the healthy volunteers that participate in this study will be compared to information from the sickle cell patients in this study in order to help further our understanding.

Primary Outcome

Comprehensively and quantitatively characterized the cardiopulmonary complications of SCD and gained an improved understanding of the pathophysiology of pulmonary hypertension and diastolic dysfunction in patients with Sickle Cell Disease.

Interventions

  • PROCEDURE MRI, Transthoracic Echocardiography, tonometry, EKG

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2009-03
Est. Completion 2021-02
University of Chicago

796 total trials

What the finished NCT01044901 record still lists

NCT01044901 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which MRI, Transthoracic Echocardiography, tonometry, EKG is the first listed.

NCT01044901 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01044901 about?

NCT01044901 is a clinical study titled "Cardiovascular Complications of Sickle Cell Disease". In this research study, we are using heart imaging exams and blood testing, in order to gain an improved understanding of the pulmonary (lung) hypertension and cardiovascular (heart) complications that often occur in sickle cell patients. Information gathered from the healthy volunteers that partici...

What is the current status of trial NCT01044901?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2009-03. Estimated completion is 2021-02.

What interventions are being tested in trial NCT01044901?

The interventions under investigation include: MRI, Transthoracic Echocardiography, tonometry, EKG (PROCEDURE).

Who is sponsoring clinical trial NCT01044901?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01044901, the US trial registry maintained by the National Library of Medicine. NCT01044901 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.